PALO ALTO, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (VINC) (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through ...

Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said Tuesday in its quarterly report. Merck, which is facing plummeting sales of ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as ...

This report, published by Towards Healthcare, a sister firm of Precedence Research, provides an in-depth analysis of the global CDMO services market for pharma and biotech. It highlights key growth ...

Merck will reduce its staff by approximately 6,000 in “some areas of our global workforce,” the New Jersey drugmaker told Fierce Pharma. The cuts will affect 8% of the company's headcount. Word of the ...

This report, published by Towards Healthcare, a sister firm of Precedence Research, provides an in-depth analysis of the ...

In this episode presented by Element Materials Technology, guests Dr. Jihye Jang-Lee and Dr. Khanh Courtney will explore how ...

Steve Ubl is president and chief executive of PhRMA, a trade group representing pharmaceutical and biotechnology companies in ...

Cost Plus Drugs is sharing pricing data with TrumpRx, the administration’s new direct-to-consumer prescription drug website ...

Shares of Sun Pharmaceutical Industries Ltd declined in Wednesday’s trade as the company disclosed that the US Food and Drug Administration (US FDA) has classified its Halol facility as Official ...

The pharmaceutical industry is entering a transformative era where Artificial Intelligence in Drug Discovery is rapidly ...